Steven Naymagon

h-index

Research activity per year

Headline

ASSISTANT PROFESSOR, Medicine, Gastroenterology

Fingerprint

Dive into the research topics where Steven Naymagon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

11 Article
3 Review article
2 Chapter
1 Letter

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms
Livanos, A. E., Jha, D., Cossarini, F., Gonzalez-Reiche, A. S., Tokuyama, M., Aydillo, T., Parigi, T. L., Ladinsky, M. S., Ramos, I., Dunleavy, K., Lee, B., Dixon, R. E., Chen, S. T., Martinez-Delgado, G., Nagula, S., Bruce, E. A., Ko, H. M., Glicksberg, B. S., Nadkarni, G. & Pujadas, E. & 33 others, Reidy, J., Naymagon, S., Grinspan, A., Ahmad, J., Tankelevich, M., Bram, Y., Gordon, R., Sharma, K., Houldsworth, J., Britton, G. J., Chen-Liaw, A., Spindler, M. P., Plitt, T., Wang, P., Cerutti, A., Faith, J. J., Colombel, J. F., Kenigsberg, E., Argmann, C., Merad, M., Gnjatic, S., Harpaz, N., Danese, S., Cordon-Cardo, C., Rahman, A., Schwartz, R. E., Kumta, N. A., Aghemo, A., Bjorkman, P. J., Petralia, F., van Bakel, H., Garcia-Sastre, A. & Mehandru, S., Jun 2021, In: Gastroenterology. 160, 7, p. 2435-2450.e34
Research output: Contribution to journal › Article › peer-review

Open Access
130 Scopus citations
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients with Inflammatory Bowel Disease
Naymagon, L., Tremblay, D., Zubizarreta, N., Moshier, E., Naymagon, S., Mascarenhas, J. & Schiano, T., 1 Feb 2021, In: Inflammatory Bowel Diseases. 27, 2, p. 215-223 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
27 Scopus citations
Gut microbiota density influences host physiology and is shaped by host and microbial factors
Contijoch, E. J., Britton, G. J., Yang, C., Mogno, I., Li, Z., Ng, R., Llewellyn, S. R., Hira, S., Johnson, C., Rabinowitz, K. M., Barkan, R., Dotan, I., Hirten, R. P., Fu, S. C., Luo, Y., Yang, N., Luong, T., Labrias, P. R., Lira, S. & Peter, I. & 54 others, Grinspan, A., Clemente, J. C., Kosoy, R., Kim-Schulze, S., Qin, X., Castillo, A., Hurley, A., Atreja, A., Rogers, J., Fasihuddin, F., Saliaj, M., Nolan, A., Reyes-Mercedes, P., Rodriguez, C., Aly, S., Santa-Cruz, K., Peters, L., Suárez-Fariñas, M., Huang, R., Hao, K., Zhu, J., Zhang, B., Losic, B., Irizar, H., Song, W. M., Narzo, A. D., Wang, W., Cohen, B. L., Dimaio, C., Greenwald, D., Itzkowitz, S., Lucas, A., Marion, J., Maser, E., Ungaro, R., Naymagon, S., Novak, J., Shah, B., Ullman, T., Rubin, P., George, J., Legnani, P., Telesco, S. E., Friedman, J. R., Brodmerkel, C., Plevy, S., Cho, J. H., Colombel, J. F., Schadt, E. E., Argmann, C., Dubinsky, M., Kasarskis, A., Sands, B. & Faith, J. J., 2019, In: eLife. 8, e40553.
Research output: Contribution to journal › Article › peer-review

Open Access
137 Scopus citations
Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature
Naymagon, L., Ward, S., Naymagon, S. & Navada, S., Apr 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19, 4, p. e165-e168
Research output: Contribution to journal › Article › peer-review

1 Scopus citations
Accelerated infliximab dosing increases 30-day colectomy in hospitalized ulcerative colitis patients: A propensity score analysis
Shah, S. C., Naymagon, S., Panchal, H. J., Sands, B. E., Cohen, B. L. & Dubinsky, M. C., 16 Feb 2018, In: Inflammatory Bowel Diseases. 24, 3, p. 651-659 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
41 Scopus citations

Steven Naymagon

Personal profile

Headline

Fingerprint

Research output

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients with Inflammatory Bowel Disease

Gut microbiota density influences host physiology and is shaped by host and microbial factors

Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature

Accelerated infliximab dosing increases 30-day colectomy in hospitalized ulcerative colitis patients: A propensity score analysis